NUVB
Nuvation Bio Inc
5.70$
+0.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -1,656.5% | -275.7% | |
| – | – | – | – | – | – | 8.7% | 2.8% | |
| – | – | – | – | – | – | 409.9% | 57.1% | |
| – | – | – | – | – | – | -158.9% | -19.0% | |
| – | – | – | – | – | – | 2.1% | 0.6% | |
| – | – | – | – | – | – | 1,558.5% | 158.2% | |
| – | – | – | – | – | – | -57.8% | 76.6% | |
| – | – | – | – | – | – | 4.2% | 322.0% | |
| – | – | – | – | – | – | -88.0% | 204.1% | |
| – | – | – | – | – | – | -1,658.5% | -276.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.